Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC. Kneuertz PJ. Ann Thorac Surg 2024;118:681-682.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kneuertz PJ. Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC. Ann Thorac Surg 2024;118:681-682.
PMID: 38508510